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Background: The Tat pathway transports folded 
proteins across energy coupling membranes. 
Results: TatA has a fixed N-out, C-in topology in 
intact cells that is not altered by the absence of 
other Tat components or over-production of a Tat 
substrate. 
Conclusion: The TatA amphipathic helix does not 
re-orient during protein translocation. 
Significance: Topological inversion of TatA does 
not accompany protein transport by the Tat 
pathway. 
 
SUMMARY 
The twin-arginine protein transport (Tat) 
system translocates folded proteins across the 
cytoplasmic membrane of prokaryotes and the 
thylakoid membrane of chloroplasts. In 
Escherichia coli TatA, TatB and TatC, are 
essential components of the machinery. A 
complex of TatB and TatC acts as the substrate 
receptor, whilst TatA is proposed to form the 
Tat transport channel. TatA and TatB are 
related proteins that comprise an N-terminal 
transmembrane helix and an adjacent 
amphipathic helix. Previous studies addressing 
the topological organization of TatA have given 
conflicting results. In this study we have 
addressed the topological arrangement of TatA 
and TatB in intact cells by labelling of 
engineered cysteine residues with the 
membrane impermeable thiol reagent 
methoxypolyethylene glycol maleimide. Our 
results show that TatA and TatB share an N-
out, C-in topology, with no evidence that the 
amphipathic helices of either protein are 
exposed at the periplasmic side of the 
membrane. We further show that the N-out, C-
in topology of TatA is fixed and is not affected 
by the absence of other Tat components or by 
the overproduction of a Tat substrate. These 
data indicate that topological reorganization of 
TatA is unlikely to accompany Tat-dependent 
protein transport. 
_________________________________________ 
      The Sec and Tat pathways operate in parallel 
to transport proteins across the cytoplasmic 
membrane of bacteria and archaea and the 
thylakoid membrane of plants. Whilst the Sec 
machinery can only export unfolded proteins, 
substrates of the Tat pathway are folded prior to 
transport. Transport by the Tat pathway is driven 
solely by the transmembrane proton 
electrochemical gradient, p (reviewed in (1,2). 
Substrates are targeted to each of these transport 
machineries by means of N-terminal cleavable 
signal peptides. One of the major distinguishing 
features of Tat targeting signals is that they contain 
a conserved twin arginine motif, which harbors 
consecutive and usually invariant arginine residues 
that are essential for efficient transport by the Tat 
machinery (3,4).  
      In Gram negative bacteria and in plant 
thylakoids, the Tat machinery is made up of three 
membrane proteins which in Escherichia coli are 
termed TatA, TatB and TatC (5-8). In E. coli a 
fourth protein, TatE, is a minor component of the 
Tat pathway and has an identical function to TatA 
(7,9). The TatA and TatB proteins share some 
primary sequence homology and evolved from a 
common ancestor, but have functionally distinct 
roles during Tat transport (8,10). TatB is found 
almost exclusively as part of the TatBC complex 
(11). This complex, which contains multiple 
copies of each protein, interacts with twin arginine 
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signal peptides and acts as the receptor for Tat 
substrates (11-16).  
      TatA can be purified as an array of large 
homo-oligomeric complexes. Analysis of these 
complexes by negative stain electron microscopy 
reveals that they form a series of related channel-
like structures of different sizes, with internal 
cavities big enough to accommodate folded 
proteins, consistent with the idea that TatA forms 
the protein conducting channel (17,18). Large 
assemblies of fluorophore-tagged TatA have also 
been observed in vivo, and homo-oligomers 
containing at least 16 copies of the plant ortholog 
of TatA, Tha4, have been detected by cross-linking 
during Tat transport in thylakoid membranes 
(19,20). In E. coli cells the formation of TatA 
assemblies is dependent upon the presence of the 
TatBC complex. In the absence of TatB or TatC, 
TatA is arranged as much smaller units, possibly 
tetramers, suggesting that interaction with TatBC 
is required to drive the polymerisation of smaller 
units of TatA into larger assemblages (20). In 
resting thylakoid membranes, cross-linking studies 
of Tha4 are also consistent with this protein 
existing as a tetrameric unit (19). Transient 
interactions of Tha4 with the thylakoid equivalent 
of the TatBC complex have detected by cross-
linking, dependent upon the presence of substrate 
and a p (21).  
      The TatA and TatB proteins have a common 
structural arrangement, comprising a single 
transmembrane helix (TMH), followed by an 
amphipathic helix (APH) and an unstructured C-
terminal tail (18,22; Fig 1A,B). Application of the 
positive inside rule (23) would suggest that the N-
termini of both proteins are located at the 
periplasmic side of the membrane with the C-
termini in the cytoplasm, and this is consistent 
with protease accessibility experiments which 
indicated that the C-termini of TatA and TatB are 
only accessible to protease digestion in inside-out 
and not right-side-out membrane vesicles (18,22). 
A similar topology was inferred from protease 
mapping of Tha4 in isolated thylakoids (24). The 
N-out topology of TatA is also supported by the 
observation that the TatA protein from 
Providencia stuartii, which is synthesized with an 
inactivating N-terminal extension of eight amino 
acids, is processed by a membrane-embedded 
rhomboid protease which has its active site close 
to the periplasmic face of the membrane (25-27). 
However, a recent study probing the accessibility 
of cysteine substituted TatA to sulfhydryl labelling 
reagents in whole cells appeared to show that the 
N-terminus of TatA was localized at the 
cytoplasmic side of the membrane (28). 
      Some models for Tat transport assume that the 
APH of TatA may re-orient during transport (Fig 
1C), for example by folding into a channel 
assembled from TatA transmembrane helices like 
a trap-door in response to a pulling force on the 
substrate (1,29,30). Early support for this model 
was provided by Gouffi et al. (31) who used 
compartment-sensitive marker proteins fused to 
the end of the APH of TatA to infer that this region 
of TatA was exposed at both sides of the 
membrane. Similar dual topology was also seen 
when a much smaller fusion, that of a TEV 
protease cleavage sequence, was inserted between 
residues 53 and 54 of TatA since this site was also 
shown to be protease accessible from either side of 
the membrane. This led the authors to conclude 
that the TatA APH has a dual topology and that 
topology changes of this region of TatA are 
associated with protein transport (31). Support for 
a helical hairpin arrangement of TatA was also 
provided by Chan et al. (28) who showed that in 
whole cells cysteine residues in the APH or C-
terminus of TatA were not labelled by a 
membrane-impermeable thiol reagent. They 
further showed that in the presence of an 
uncoupler the labelling pattern of a cysteine 
present in the APH of TatA was altered, 
suggesting that topological changes in the APH 
were dependent upon p.  
      In this study we have re-visited the topological 
organization of TatA and TatB in whole cells by 
direct labelling of engineered cysteine residues. 
Our results clearly show that TatA has a fixed N-
out, C-in topology that is not altered by the 
absence of other Tat components or by the 
overproduction of a Tat substrate.  
 
EXPERIMENTAL PROCEDURES 
      E. coli Strains and Plasmids. Strains and 
plasmids used in the present work are shown in 
Tables 1 and 2, respectively. All strains used in 
this study are derivatives of MC4100 (32).  
      Plasmids in strain DADE-P (22) were used to 
overexpress the E. coli tatABC operon with alanine 
substitutions of all four cysteine codons in tatC 
and single cysteine codon substitutions in tatA or 
tatB. Cysteine substitutions were introduced by 
QuikChange™ site-directed mutagenesis 
(Stratagene) in plasmid pUNITATA (30) or 
UNITATB (22) resulting in plasmid series 
pUNITATAX#C or pUNITATBX#C, respectively, 
where X corresponds to the single letter amino 
acid code and # to the position of the substituted 
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codon. Each tatA mutation was sub-cloned into the 
EcoRI and PmlI sites of plasmid pUNITATCC4 
(22) giving rise to plasmid series 
pUNITATCC4AX#C. Each tatB mutation was 
sub-cloned into the PmlI and AflII sites of plasmid 
pUNITATCC4 (22) giving rise to plasmid series 
pUNITATCC4BX#C. Primer sequences used for 
QuikChange™ mutagenesis are available on 
request. 
      For the cysteine insertion between residues 1 
and 2 of TatA, DNA covering the tatA start codon 
and upstream DNA was amplified with primers 
TatPromXcaBamrev (5’-GCGCGGATCCGTATA 
CATGTTCCTCTGTGGTAGATG-3’) and 
TATA5 (7) and cloned into the EcoRI and BamHI 
sites of pBluescript KS+ (Stratagene) to give 
plasmid pBSTatAPromXcaI. Plasmid 
pBSTatAins2C was constructed following 
amplification of tatA using primers TatAins2C (5’-
TGTGTGGTGGTATCAGTATT-3’) and 
TatAEcPmlBam (5’-GCGCGGATCCCACGTGT 
TACACCTGCTCTTTATCG-3’) and subsequent 
cloning of the PCR product into the BamHI and 
XcaI (blunt-end) sites of plasmid 
pBSTatAPromXcaI. The tatA gene with the 
cysteine insertion was subsequently excised by 
digestion with EcoRI and PmlI and cloned into 
similarly digested pUNITATCC4 to give 
pUNITATCC4Ains2C. 
      A cysteine insertion between codons G21 and 
T22 was constructed as follows. DNA covering 
tatA up to codon 21 was amplified using primers 
TatATMH1 (5’-GCGCGGATCCTGGCCAAAAA 
GCAGTACAACGATGA-3’) and TATA5 and 
cloned into pBluescript as an EcoRI-BamHI 
fragment. DNA covering tatA from codon 22 
onwards was amplified using TatAGly1 (5’-
CGGCACCAAAAAGCTCGGCTCCATCGG-3’) 
and UNIA1 (30), digested with BamHI and cloned 
into the above plasmid that had been previously 
digested with MscI (blunt end) and BamHI, to give 
plasmid pTatAGly1. This construct codes for TatA 
with a glycine insertion between G21 and T22. 
The extra gly codon was subsequently changed to 
a cys codon by QuikChange™ site-directed 
mutagenesis to give plasmid pBSTatAins21C. The 
tatA genes with the cysteine insertion was 
subsequently excised by digestion with EcoRI and 
PmlI and cloned into similarly digested 
pUNITATCC4 to give plasmid 
pUNITATCC4Ains21C.  
      The tatABC operon in single copy harboring 
single cysteine codon substitutions in tatA and 
alanine substitutions of all four cysteine codons of 
tatC, was expressed from the chromosomal lambda 
phage attachment site, attB, of strain DADE (33). 
The tatA gene and approximately 100 bp of 
upstream promoter region were amplified from E. 
coli chromosomal DNA with primers UNIREP1 
and UNIA1 and cloned into the EcoRI and BamHI 
sites of pBluescript KS+ generating plasmid 
pKSuniA. Single cysteine substitutions in tatA 
were introduced by QuikChange™ site-directed 
mutagenesis in pKSuniA giving plasmid series 
pKSuniAX#C. The tatABC operons under control 
of the tatA promoter in plasmids pUNICC‒AX#C 
were sub-cloned into the EcoRI and BamHI sites 
of plasmid pRS552 (34) resulting in plasmid series 
pRSUNICC‒AX#C. The tatABC operon under 
control of the tatA promoter from pRSUNICC‒
AX#C was subsequently integrated into the attB 
site of strain DADE as described (34) resulting in 
strains MF1–13 (Listed in Table 1). A series of 
strains expressing only tatA were also constructed. 
In this case, the tatA variants with single cysteine 
substitutions under control of the tat promoter in 
the pUNITATAX#C plasmid series were sub-
cloned into the EcoRI and BamHI site of pRS552 
and subsequently integrated into the attB site of 
strain DADE resulting in strains SK1–13 (Table 
1). 
      The Paracoccus panthotrophus soxYZ genes 
were amplified from plasmid pVS005 (35) using 
primers BamHAsoxY (5-GCGCGGATCCATGTA 
TCCGTACGATGTGCCGGACTATGCGAGCAC
CGTTGACGAGTTG-3’) and soxZHind (5’-
GCGCAAGCTTTTAGGCGACTGCG). This also 
introduces an N-terminal hemagglutinin-tag (HA-
tag) in place of the SoxY signal sequence. The 
soxYZ PCR product (as a BamHI-HindIII 
fragment) and the tatA promoter (released as an 
EcoRI-BamHI fragment from pSUPROM (36) 
were cloned by three-way ligationn into EcoRI-
HindIII-digested pSU20 (37) to give plasmid 
pHASoxYZ (38). The tatA promoter and soxYZ 
from pHASoxYZ were subsequently cloned into 
the EcoRI and HindIII sites of the low-copy vector 
pTH19cr (39) resulting in plasmid pTH19SoxYZ. 
      Culture Conditions, Fractionation and Protein 
Methods. Unless indicated otherwise, liquid 
cultures were inoculated with 1/100 volume of an 
overnight culture in LB medium supplemented 
with appropriate antibiotics and grown with 
vigorous shaking at 37° (40). Growth assays to test 
resistance to SDS were performed as described 
(41). Growth assays to test Tat-dependent growth 
with trimethylamine-N-oxide (TMAO) as sole 
electron acceptor were carried out by growing 
strains anaerobically at 37°C for up to four days on 
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solid M9 minimal medium supplemented with 
0.4% (w/v) TMAO and 0.5% (v/v) glycerol (41).  
Cultures for TMAO reductase assays were grown 
anaerobically in 50 ml LB medium supplemented 
with 0.4% (w/v) TMAO and 0.5% (v/v) glycerol at 
37°C overnight (8). Cells were separated into 
spheroplast and periplasmic fractions using 
lysozyme/EDTA treatment in a high sucrose buffer 
followed by centrifugation (42). 
TMAO:benzylviologen oxidoreductase activity 
was measured in periplasmic fractions of TMAO-
grown cells as described previously (43). 
      SDS-PAGE and immunoblotting analysis was 
performed as described (44,45) and 
immunoreactive bands were detected using a 
chemiluminescent horseradish peroxidase (HRP) 
substrate kit (Millipore). Antisera against E. coli 
TatA and TatB (46) were used to detect the 
proteins, with an anti-rabbit IgG HRP conjugate 
(Bio-Rad) used as secondary antibody. SufI was 
detected using a polyclonal anti-SufI antiserum 
(41). Hemagglutinin-tagged SoxY was detected 
with anti-hemagglutinin tag (HA tag) HRP 
conjugate (Sigma-Aldrich). 
      Sulfhydryl Labelling. For sulfhydryl labelling 
with crude membrane fractions, cells were grown 
in 25 ml LB medium at 37°C overnight, harvested 
by centrifugation at 5000 × g and washed in Buffer 
K (50 mM triethanolamine-HCl, pH 7.5, 250 mM 
sucrose, 1 mM Na2EDTA). Cell pellets were 
resuspended in 1 ml Buffer K supplemented with 
protease inhibitors (Complete Mini, EDTA-free 
protease inhibitor mixture tablets; Roche Applied 
Science). Cells were disrupted on ice by five 
cycles of sonication with 15 second pulses and 15 
second intervals in between. Cell debris was 
pelleted by centrifugation at 16,000 × g for 10 
minutes and the crude membrane fraction was 
pelleted from the supernatant by ultra-
centrifugation at 278,000 × g for 30 minutes. The 
crude membrane fraction was resuspended in 1 ml 
HEPES/NaCl buffer (50 mM HEPES, pH 6.8, 50 
mM NaCl) and diluted to 10–15 µg µl−1 of total 
protein. 10 µl of the membrane fraction were 
labelled with 5 mM Methoxypolyethylene glycol 
maleimide (MW 5000 Da, Sigma-Aldrich) in a 
final volume of 50 µl HEPES/NaCl buffer at room 
temperature for one hour. Control samples were 
incubated with buffer alone or were treated with 
1% Triton-X 100 or 1% sodium dodecyl sulfate 
prior to labelling. The sulfhydryl labelling reaction 
was stopped by addition of 5 µl 0.5 M 
dithiothreitol (DTT) and mixed 1:1 with 2× 
Laemmli sample buffer (Bio-Rad). 
      For sulfhydryl labelling with intact cells, 
cultures were grown at 37°C to mid-logarithmic 
phase and normalised to an OD600 of 0.3. Cells 
were harvested by centrifugation at 5000 × g, 
washed with HEPES/MgCl2 buffer (50 mM 
HEPES, pH 6.8, 5 mM MgCl2) and cell pellets 
were resuspended in 1 ml of HEPES/MgCl2 buffer. 
80 µl of cell suspension were incubated with 5 
mM Methoxypolyethylene glycol maleimide 
(MAL-PEG) at room temperature for one hour in 
presence of 5 mM EDTA and in a final volume of 
100 µl HEPES buffer. The sulfhydryl labelling 
reaction was stopped with 25 µl 0.5 mM DTT and 
proteins were precipitated as described (47). 
Protein precipitates were resolubilized in 70 or 100 
µl 2× Laemmli sample buffer depending if TatA 
variants of samples were expressed from the 
chromosome or from plasmid, respectively.  
 
RESULTS 
      Cysteine-substituted TatA proteins can be 
labelled with methoxypolyethylene glycol 
maleimide (MAL-PEG). Previous studies looking 
at cysteine accessibility of E. coli TatA and TatC 
proteins have used an indirect method to detect 
sulfhydryl labelled proteins (28,48). N-(3-
maleimidylpropionyl)-biocytin or MPB is a 
membrane permeable maleimide reagent with a 
molecular mass of around 500 Da that can 
subsequently be detected by binding of 
streptavidin. 4-acetamido-4'-maleimidylstilbene-
2,2'-disulfonic acid (AMS) is a membrane 
impermeable maleimide of similar molecular mass 
to MPB. Periplasmically-located cysteines in TatA 
and TatC were identified by pre-treating cells with 
AMS, which will only react with external 
cysteines, followed by MPB, which will react with 
any cysteines that have not been previously 
labelled with AMS (28,48). Since these reagents 
effectively do not alter the apparent mass of the 
protein with which they react, labelling can only 
be detected once the protein has been purified and 
incubated with streptavidin. According to this 
method periplasmic cysteines are identified 
because they show a lower level of MPB labelling 
than cytoplasmic cysteines. 
      Because this approach is rather time-
consuming, and requires significant amounts of 
material (due to losses at the purification step), we 
employed a more direct approach to assess 
cysteine accessibility. Methoxypolyethylene glycol 
maleimide (MAL-PEG) is a membrane-
impermeable maleimide of much larger mass 
(approx. 5,000 Da) that results in a clear size-shift 
of the labelled protein which can be detected by 
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western blotting (38,49). To assess whether 
cysteine substitutions in TatA that might be 
expected to lie close to the membrane were 
accessible to labelling by the relatively large 
MAL-PEG reagent, we firstly isolated membrane 
fractions from E. coli strains producing plasmid 
encoded TatA variants along with TatB and a 
cysteine-less variant of TatC. Cysteine residues 
close to the N-terminus of TatA (i.e. a G2C 
substitution or a variant with a cys insertion 
between M1 and G2 termed Ins2C) clearly reacted 
with MAL-PEG to give a species that migrated 
more slowly than unlabelled TatA (Fig 2A). Also 
as expected a TatA protein lacking cys residues 
did not label with MAL-PEG, and a cys residue 
that is predicted to be buried in the TMH (I12C) 
did not label with MAL-PEG unless detergent was 
also included in the labelling reaction. 
      Cysteine residues in the hinge region between 
the TMH and APH showed poor labelling in the 
absence of detergents (Fig 2B). Thus cys residues 
at positions 18, 19 and 20 did not react with MAL-
PEG in isolated membranes, nor did a cys residue 
that had been inserted between G21 and T22. The 
first residue in this hinge region to become 
accessible to PEGylation was a cys substitution of 
position 22. This suggests that the preceding 
residues are buried within the membrane, which is 
in accordance with the findings of a solid state 
NMR study on the Bacillus subtilis TatAd protein 
(50). All of the cys substitutions that were tested 
along the APH were freely accessible to MAL-
PEG labelling in isolated membranes (Fig 1C), 
indicating that for at least a proportion of the TatA 
molecules the APH must lay along the membrane 
rather than being in a transmembrane orientation. 
      Labelling of accessible cys residues with MAL-
PEG in intact cells. The outer membranes of Gram 
negative bacteria are generally permeable to 
hydrophilic molecules < 600 Da due to the 
presence of porins, but do not allow passage of 
molecules larger than this. Therefore to test 
whether any of the membrane-extrinsic cys 
substitutions of TatA were accessible to MAL-
PEG in whole cells, it was necessary to devise a 
method which would allow the compound to 
permeate across the outer membrane. EDTA 
chelates divalent metal ions that are associated 
with the lipopolysaccharide, offsetting their 
stabilizing effect and increasing permeability (51). 
We therefore added 5mM EDTA to cell 
suspensions prior to addition of MAL-PEG. 
Control experiments showed that the EDTA 
treatment did not affect the viability of cells (Fig 
S1). 
      MAL-PEG accessibility was tested for TatA 
variants harboring cys substitutions at position 2, 
Ins2 and 22 to determine the topology of the TMH, 
and 33, 35, 39, 41, 45, 47, 49, 60, 78 and 89 to 
determine the localization and topology of the 
APH and C-terminal tail. Some of these cys 
substitutions have been described previously (30) 
and it was shown that the G2C, S35C and K41C 
variants supported a high level of Tat transport 
activity, T22C supported a low but detectable level 
of Tat transport whilst G33C and F39C inactivated 
the function of TatA. When we assessed the 
activity of all of the new substitutions constructed 
here (Ins2C, D45C, E47C, K49C, T60C, T78C and 
V89C) each of them supported high Tat transport 
activity (Fig S2A) indicating that TatA function 
was preserved. 
      As a control for each of the labelling reactions 
the E. coli strains co-produced a cytoplasmic form 
of the Paracoccus pantotrophus SoxY protein 
carrying an N-terminal hemagglutanin epitope tag. 
This protein contains a highly exposed single cys 
residue on a flexible arm at the C-terminus of the 
protein (35) and any MAL-PEG labelling of this 
indicated that the integrity of the cytoplasmic 
membrane was compromised.  
      TatA variants containing cys substitutions at 
the N-terminus were clearly accessible to 
PEGylation in intact cells, whilst the T22C variant 
was not (Fig 3A). The T22C variant was, however, 
PEGylated in the presence of SDS. Analysis of 
SoxY labelling indicated that the cytoplasmic 
membrane was not breached during the procedure. 
These data show that the TatA TMH has an N-out, 
C-in topology. We noted that the detectability of 
SoxY and TatA appears to increase dramatically 
after PEGylation. This may be due to better 
transfer and/or increased binding of the PEGylated 
proteins to the nitrocellulose membrane during 
electroblotting.  
      Fig 3B and C show the labelling patterns for 
cys residues located in the APH (Fig 3B) and C-
tail (Fig 3C). Each of the positions gives a 
labelling pattern that is identical to that for T22C, 
with the single exception of the V89C substitution, 
which showed some labelling in the absence of 
SDS. However, in this case we noticed that the 
integrity of the inner membrane was compromised 
resulting in PEGylation of SoxY. We routinely 
observed that the plasmid-produced V89C 
substitution induced leakage of the inner 
membrane towards MAL-PEG, for reasons that are 
not clear. However, taken together the results 
clearly indicate that the APH and C-tail of TatA 
have a cytoplasmic localization, with no evidence 
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that the APH can flip across the membrane.  
      TatA shows the same topology when produced 
at native levels and in the absence of TatBC. All of 
the results obtained above, and in the experiments 
undertaken by Chan et al. (28) studied TatA 
variants that were overproduced from a multicopy 
plasmid (along with TatB and TatC). It has been 
shown that even a relatively low level of tatABC 
overexpression can result in an aberrant 
localization of TatA, which accumulates in the 
cytoplasm as tube-like structures (52). The 
presence of cytoplasmic forms of TatA might be 
expected to interfere with labelling experiments 
because a proportion of the TatA protein will have 
its N-terminus located in the cytoplasm rather than 
in a transmembrane orientation. We therefore 
repeated our PEGylation experiments with TatA 
proteins produced at chromosomal levels. 
      DNA encoding TatA variants G2C, ins2C, 
T22C, G33C, S35C, F39C, K41C, D45C, E47C, 
T60C, T78C, V89C along with TatB and cysteine-
less variant of TatC, under the control of the tatA 
promoter were placed into the lambda phage 
attachment site, attB, on the chromosome of strain 
DADE (which is deleted for all natively-encoded 
tat genes). The activity of the Tat system 
producing these variants at chromosomal level was 
assessed by determining the activity of the Tat 
substrate, trimethylamine-N-oxide (TMAO) 
reductase, TorA, in the periplasmic fraction. As 
shown in Fig 4, the S35C, D45C, E47C, T78C and 
V89C variants had levels of periplasmic TorA 
activity that was indistinguishable from the strain 
carrying wild type tatABC at the attB site. The 
other strains had very low levels of periplasmic 
TorA activity, close to that seen for the negative 
control. These strains were also examined for Tat 
activity using two phenotypic growth tests, growth 
on media containing 2% SDS (which requires the 
export of the Tat-dependent cell wall amidases, 
AmiA and AmiC; 53,54) and growth on minimal 
medium containing TMAO as sole electron 
acceptor (which assesses the combined export of 
TorA and the membrane-bound dimethylsulfoxide 
reductase, which can also reduce TMAO). All 
strains were able to grow on 2% SDS with the 
exception of those producing TatA variants G33C 
and T60C. Likewise all strains could grow with 
TMAO as sole electron acceptor except for those 
producing the ins2C, T22C, G33C, F39C and 
K41C TatA variants. Taken together it would seem 
that at native expression level the G33C 
substitution of TatA completely inactivates Tat 
function, whereas the remaining substitutions 
allow detectable transport of at least one Tat 
substrate protein. 
      We next confirmed that all of the variant TatA 
proteins were stably produced (Fig S3) and then 
we repeated the MAL-PEG accessibility assays in 
EDTA permeabilised whole cells. It is clear from 
the data shown in Fig 5 that cys residues close to 
the N-terminus of TatA were accessible to reaction 
with MAL-PEG in the absence of SDS (Fig 5A), 
and thus reside at the periplasmic side of the 
membrane. By contrast cys substitutions in the 
hinge region, the APH or C-tail of TatA could only 
be PEGylated in the presence of SDS (Fig 5A-C), 
consistent with cytoplasmic localization of these 
regions. Thus it is clear that the topology of TatA 
produced at close to native levels, is similar to that 
of overproduced TatA. 
      To ascertain whether the topology of TatA was 
affected by the presence of other Tat components 
we constructed a series of analogous strains where 
mutant tatA genes alone were expressed from the 
attB site of strain DADE. These cysteine-
subsituted TatA variants, which were again shown 
to be stably produced (Fig S3), gave MAL-PEG 
labelling results that were largely indistinguishable 
from the labelling results obtained in the presence 
of TatBC (compare Fig 5 and Fig 6). We conclude 
that TatA has a similar N-out, C-in topology in the 
presence or absence of other Tat components.   
      Overproduction of a Tat substrate does not 
alter the topology of the TatA APH. The results 
presented above support an N-out, C-in topology 
for TatA under all conditions tested, and provide 
no evidence for dual topology of the APH 
suggested by others (28,31). Whilst the cells 
clearly remained viable and presumably also 
transport active during the EDTA treatment and 
PEGylation procedure (Fig S1), we maximized the 
likelihood that the Tat machinery was operational 
during the labelling experiments by saturating the 
Tat pathway through the high-level overproduction 
of the plasmid-encoded Tat substrate SufI. As 
shown in Fig 7A, SufI was massively 
overproduced from this construct when compared 
to native level, and the Tat machinery appeared to 
be saturated since there was significant SufI 
present in the spheroplast fraction. It can also be 
seen that some SufI was detected in the 
periplasmic fractions of strains producing each of 
the G33C, S35C, F39C, K41C, D45C and E47C 
TatA proteins, confirming functionality of the 
variant Tat machineries, even for those TatA 
proteins that supported only low levels of Tat 
transport of TorA. Differential effects of tat point 
mutations have previously been noted, depending 
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upon the nature of reporter proteins used to assess 
functionality of the Tat system and on whether Tat 
components or substrates proteins are 
overproduced (2). Control experiments (Fig 7A) 
showed that there was little disruption to the 
spheroplasts during the procedure since no HA-
tagged SoxY could be detected in the periplasmic 
fractions. It should be noted that the SufI protein 
present in the spheroplast fractions had 
approximately the same mobility as that in the 
periplasmic fraction. It has been shown previously 
that SufI overproduced from the same construct 
used here is subjected to proteolytic processing of 
the N-terminal 17 amino acids, presumably by a 
cytoplasmic protease (55). Alternatively these 
observations may suggest that there is incomplete 
spheroplast formation in these experiments.  
      When the one hour PEGylation reaction was 
repeated in the presence of overproduced SufI, 
again none of the cys residues tested reacted with 
the MAL-PEG unless SDS was also included in 
the samples (Fig 7B). Thus we conclude that it is 
extremely unlikely that the TatA APH becomes 
exposed at the periplasmic side of the membrane 
during substrate transport. 
      TatB has an N-out, C-in topology assessed by 
MAL-PEG accessibility. To confirm that TatA and 
TatB show similar overall topology we applied the 
same MAL-PEG labelling approach to cysteine-
substituted TatB proteins. Cysteine substitutions at 
position 2 and 41 of TatB were already available 
(22) and we constructed a further three 
substitutions, two more in the extended APH of 
TatB at positions 45 and 50, and a substitution at 
the very C-terminus of the protein (P171C). 
Previous studies have shown that TatB is tolerant 
to mutagenesis (22,56) and indeed each of the cys-
substituted TatB proteins supported a good level of 
Tat activity (Fig 8A).  
      In these experiments the TatB variants were 
produced from a plasmid along with TatA and a 
cysteine-less variant of TatC, in a strain that was 
devoid of chromosomally-encoded Tat 
components. MAL-PEG labelling in whole cells 
demonstrated that the only cysteine accessible to 
PEGylation in the absence of SDS was at position 
2 (Fig 8B), confirming that the N-terminus of TatB 
resides at the periplasmic side of the membrane. 
Cys residues in the APH and C-terminus of TatB 
were not PEGylated unless SDS was also included 
in the reaction, indicating that these residues most 
likely reside at the cytoplasmic side of the 
membrane. We therefore conclude that TatB has 
the same topological organization as TatA. 
 
 
DISCUSSION 
      The development of even the most basic 
models for Tat pathway function requires 
knowledge about the location and topology of the 
essential Tat components. Whilst the membrane 
localization of the E. coli TatABC components is 
not in doubt (e.g. 57), the orientation and number 
of membrane-spanning domains present in TatA 
has been a source of contention. Previously the 
only experimental evidence directly addressing the 
location of the N-terminus of TatA led to the 
conclusion that it resided at the cytoplasmic side of 
the membrane, contrary to the positive inside rule 
(28). Furthermore, two separate studies indicated 
that the APH of TatA showed dual topology, being 
exposed at both the cytoplasmic and periplasmic 
side of the membrane. This supported models 
where the topological re-orientation of the TatA 
APH accompanied substrate movement across the 
membrane (1,29,30).  
      In this study we re-examined the topology of 
E. coli TatA, as well as addressing for the first 
time the topological orientation of the related 
protein TatB. We developed a method which 
would allow direct detection of labelled cysteine 
residues introduced at strategic positions 
throughout each protein by a size shift, whilst at 
the same time ensuring that the cytoplasmic 
membrane remained intact. Our results clearly 
showed that the N-termini of TatA and TatB are 
exposed at the periplasmic side of the membrane 
whilst residues along the APH and within the C-
termini of both proteins were not labelled unless 
the inner membrane was dispersed with detergent. 
Topological changes of the TatA APH have been 
linked to substrate transport (31), however even 
when we grossly over-produced the Tat substrate 
SufI we did not detect any trace of exposure of any 
cysteines in the APH at the periplasmic side of the 
membrane. Since the cells clearly remained viable 
during these experiments, which were carried out 
at room temperature, it is reasonable to suppose 
that the Tat system was still functional during this 
time. Coupled with the observations that at least 
some of the TatA variants we tested were not 
impaired for Tat function, we conclude that Tat 
transport is not accompanied by exposure of the 
APH to the periplasm. 
      We also addressed the accessibility of cys 
residues located around the hinge region of TatA, 
between the TMH and APH. The results indicate 
that most of the hinge region is buried within the 
membrane and not accessible to PEGylation. This 
is in agreement with a solid-state NMR 
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spectroscopy study of a truncated Bacillus subtilis 
TatAd construct comprising just the TMH and 
APH reconstituted into lipid bicelles (50). It was 
shown that the N-terminal part of the APH is 
pulled into the membrane by virtue of the fact that 
the TMH is unusually short. A solution NMR 
study of the same protein also showed that the 
hinge region was unexpectedly rigid rather than 
flexible with extensive contacts between residues 
F14, L18, P23 and L26 (58). The rigidity of this 
region results in quite a steep upward tilt of the 
APH (50) and would be expected to constrain 
movement of the APH relative to the TMH. It is 
not known whether the hinge region of E. coli 
TatA is similarly rigid, particularly since most of 
the residues in TatAd involved in this interaction 
network are not conserved between the two 
proteins. However whilst it would appear that the 
TMH-APH hinge region plays an essential role in 
TatA function, it is unlikely to act as a pivot that 
allows these two domains of TatA to form a helical 
hairpin. Future models for Tat transport should 
consider alternative functions for the TatA APH.  
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FIGURE LEGENDS 
 
FIGURE 1. Secondary structure predictions of the E. coli TatA and TatB proteins and possible topological 
arrangements of TatA. Primary amino acid sequence of A. E. coli TatA; B. E. coli TatB. The position of the 
invariant glycine found throughout TatA and TatB family proteins is boxed. Predicted secondary structure 
elements are shown above the amino acid sequences, with the transmembrane helix in dark grey and the 
amphipathic helix in light grey. Secondary structure predicted using PSIPRED 3.0 (59) and predicted helical 
regions are shown as cylinders; Note only the first 100 amino acids of TatB are shown. C. Possible 
topological organizations for E. coli TatA based on previous experimental observations.  
 
FIGURE 2. MAL-PEG labelling of cysteine-substituted TatA in crude membrane fractions of E. coli. Cells of 
strain DADE-P (ΔtatABCD, ΔtatE, pcnB) producing plasmid encoded TatB and cysteine-less TatC along with 
either wild type TatA (WT) or the indicated TatA cys-substituted variants were disrupted by sonication. The 
crude membrane fraction was isolated by ultracentrifugation and divided into four aliquots (each of 100 – 150 
µg protein). One aliquot was incubated with buffer alone, whilst the remaining three aliquots were incubated 
with MAL-PEG, MAL-PEG plus 1 % Triton-X 100 or MAL-PEG plus 1 % SDS. The reaction was quenched 
by addition of with 45 mM DTT and a sample of each aliquot (4.5 – 7 µg protein) was separated by SDS-
PAGE on 15% Tris-glycine gels. Proteins were transferred to nitrocellulose membrane and TatA was detected 
with anti-TatA antiserum. The positions of the molecular weight markers are indicated to the left of the panels 
and the positions of unlabelled and PEGylated TatA to the right of the panels. A possible TatA-lipid cross-link 
seen for some of the TatA variants and reported previously (30) is indicated with an asterisk. Labelling of 
TatA cys substitutions shown for A. the N-terminus and within the TMH; B. around the hinge region and C. in 
the APH. 
 
FIGURE 3. MAL-PEG labelling of plasmid produced, cysteine-substituted TatA in intact cells shows an N-
out, C-in topology. Cells of strain DADE-P (ΔtatABCD, ΔtatE, pcnB) producing plasmid encoded TatB and 
cysteine-less TatC along with either wild type TatA (WT) or the indicated TatA cys-substituted variants in 50 
ml culture were grown to mid-exponential phase (OD600 of approx. 0.4), harvested and resuspended in 1 ml 
buffer. 80 µl aliquots of cell suspension were incubated with buffer alone, or 5 mM MAL-PEG in the presence 
or absence of 1% SDS for 1 hour at room temperature. Reactions were quenched with 45 mM DTT and 
proteins were precipitated with chloroform and methanol. Resolubilised samples were separated by SDS-
PAGE, electroblotted and immunoreactive bands were revealed by incubation with either anti-TatA antiserum 
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or an anti-hemagglutinin HRP conjugate (to detect SoxY). The positions of the molecular weight markers are 
indicated to the left and the positions of PEGylated and non-PEGylated protein to the right. Labelling of TatA 
cys substitutions shown for A. either side of the TMH; B. the APH and C. the C-terminal tail. 
 
FIGURE 4. Periplasmic TMAO reductase activities of E. coli strains producing chromosomally-encoded 
cysteine-substituted TatA variants. Relative TMAO reductase activities were determined in the periplasmic 
fractions of strain DADE (ΔtatABCD, ΔtatE; annotated as  in the figure) or DADE producing TatB and 
cysteine-less TatC along with either wild type TatA (strain MF1, labelled WT) or the indicated TatA variants. 
The TMAO reductase activity of strain MF1 (DADE attB::PtatA (tatABC) is classed as 100% activity and 
represents a specific activity of approximately 2.6 mol benzyl viologen oxidised/min/mg protein. The error 
bars represent the standard error of the mean, n=3. 
 
FIGURE 5. MAL-PEG labelling of chromosomally-encoded cysteine-substituted TatA in intact cells shows 
an N-out, C-in topology. Cells of strains MF2 – MF13 producing TatB, cysteine-less TatC and cysteine-
substituted TatA at chromosomal levels were grown in 50 ml culture until mid-exponential phase was 
reached. Cells were harvested and resuspended in 1 ml HEPES/MgCl2 buffer. 80 µl aliquots of cell suspension 
were incubated with buffer alone, or 5 mM MAL-PEG in the presence or absence of 1% SDS for 1 hour at 
room temperature. Reactions were quenched with 45 mM DTT, proteins were precipitated with chloroform 
and methanol and separated by SDS PAGE. After electroblotting, TatA was detected with anti-TatA 
antiserum and SoxY using an anti-hemagglutinin HRP conjugate. The positions of the molecular weight 
markers are indicated to the left and the positions of PEGylated and non-PEGylated protein to the right. 
Labelling of TatA cys substitutions shown for A. either side of the TMH; B. the APH and C. the C-terminal 
tail. 
 
FIGURE 6. TatA has an N-out, C-in topology in the absence of other Tat components. Cells of strains SK2 – 
SK13 producing cysteine-substituted TatA at chromosomal levels in an otherwise tat- background were grown 
in 50 ml culture until mid-exponential phase was reached. Cells were harvested and resuspended in 1 ml 
HEPES/MgCl2 buffer. 80 µl aliquots of cell suspension were incubated with buffer alone, or 5 mM MAL-PEG 
in the presence or absence of 1% SDS for 1 hour at room temperature. Reactions were quenched with 45 mM 
DTT, proteins were precipitated with chloroform and methanol and separated by SDS PAGE. After 
electroblotting, TatA was detected with anti-TatA antiserum and SoxY using an anti-hemagglutinin HRP 
conjugate. The positions of the molecular weight markers are indicated to the left and the positions of 
PEGylated and non-PEGylated protein to the right. Labelling of TatA cys substitutions shown for A. either 
side of the TMH; B. the APH and C. the C-terminal tail. 
 
FIGURE 7. Topology of the TatA APH does not change when the Tat substrate SufI is overproduced. A. 
Overproduction and Tat-dependent transport of SufI mediated by variant TatA proteins. Cultures of strains 
MF1 (WT), MF5 (G33C), MF6 (S35C), MF7 (F39C), MF9 (D45C) and MF10 (E47C) harboring pQE-SufI 
and pTH19SoxYZ were cultured aerobically in 50 ml LB medium until an OD600 of approximately 0.6 was 
reached. Cells were harvested, washed with 50 mM HEPES, pH 7.0, 250 mM NaCl, resuspended in 1 ml 
HEPES/sucrose buffer (50 mM HEPES, pH 7.0, 0.5 M sucrose) and fractionated to give a final volume of 1ml 
periplasm (P) and 5 ml spheroplasts (S). 5 µl samples of each fraction were separated by SDS-PAGE, 
electroblotted and immunoreactive protein bands of SufI or SoxY were detected as indicated. Note that 
expression of sufI from pQE60 is constitutive in these strain backgrounds because the chromosomal copy of 
lacI is deleted. B. Cells of strains MF1, MF5, MF6, MF7, MF9 and MF10 harboring pQE-SufI and 
pTH19SoxYZ were grown in 50 ml culture until mid-exponential phase was reached. Cells were harvested 
and resuspended in 1 ml HEPES/MgCl2 buffer. 80 µl aliquots of cell suspension were incubated with buffer 
alone, or 5 mM MAL-PEG in the presence or absence of 1% SDS for 1 hour at room temperature. Reactions 
were quenched with 45 mM DTT, Proteins were precipitated with chloroform and methanol and separated by 
SDS PAGE. After electroblotting, TatA was detected with anti-TatA antiserum and SoxY using an anti-
hemagglutinin HRP conjugate. 
 
FIGURE 8. TatB has an N-out, C-in topology. A. Relative TMAO reductase activities were determined in the 
periplasmic fractions of strain DADE-P (ΔtatABCD, ΔtatE, pcnB) harboring either pQE60, or pQE60 
encoding TatA and cysteine-less TatC along with TatB variants containing a single cysteine substitution as 
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indicated. The TMAO reductase activity of strain DADE-P transformed with pUNITATCC4, encoding wild 
type TatA, TatB and cysteine-less TatC was defined as one hundred percent activity and corresponds to 1.9 
µM benzyl viologen oxidised per minute and per mg of protein. The error bars represent standard error of the 
mean, n = 3. B. Cells of strain DADE-P producing plasmid encoded TatA and cysteine-less TatC along with 
either wild type TatB (WT) or the indicated TatB cys-substituted variants in 50 ml culture were grown to mid-
exponential phase (OD600 of approx. 0.4), harvested and resuspended in 1 ml buffer. 80 µl aliquots of cell 
suspension were incubated with buffer alone, or 5 mM MAL-PEG in the presence or absence of 1% SDS for 1 
hour at room temperature. Reactions were quenched with 45 mM DTT and proteins were precipitated with 
chloroform and methanol. Resolubilised samples were separated by SDS-PAGE, electroblotted and 
immunoreactive bands were revealed by incubation with either anti-TatB antiserum or an anti-hemagglutinin 
HRP conjugate (to detect SoxY). The positions of the molecular weight markers are indicated to the left and 
the positions of PEGylated and non-PEGylated protein to the right. 
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 Description Reference 
MC4100 F−, [araD139]B/r, Δ(argF-lac)U169, λ−, e14−-, flhD5301, Δ(fruK-
yeiR)725(fruA25), relA1, rpsL150(StrR), rbsR22, Δ(fimB-
fimE)632(::IS1), deoC1 
(32) 
JARV16-P MC4100 ΔtatA ΔtatE pcnB1 zad-981::Tn10d (8) 
DADE MC4100 ΔtatABCD ΔtatE (33) 
DADE-P MC4100 ΔtatABCD ΔtatE pcnB1 zad-981::Tn10d (22) 
MF1 DADE attB::PtatA (tatABC) This study 
MF2 DADE attB::PtatA (tatAins2CBC) This study 
MF3 DADE attB::PtatA (tatAG2CBC) This study 
MF4 DADE attB::PtatA (tatAT22CBC) This study 
MF5 DADE attB::PtatA (tatAG33CBC) This study 
MF6 DADE attB::PtatA (tatAS35CBC) This study 
MF7 DADE attB::PtatA (tatAF39CBC) This study 
MF8 DADE attB::PtatA (tatAK41CBC) This study 
MF9 DADE attB::PtatA (tatAD45CBC) This study 
MF10 DADE attB::PtatA (tatAE47CBC) This study 
MF11 DADE attB::PtatA (tatAT60CBC) This study 
MF12 DADE attB::PtatA (tatAT78CBC) This study 
MF13 DADE attB::PtatA (tatAV89CBC) This study 
SK1 DADE attB::PtatA (tatA) This study 
SK2 DADE attB::PtatA (tatAins2C) This study 
SK3 DADE attB::PtatA (tatAG2C) This study 
SK4 DADE attB::PtatA (tatAT22C) This study 
SK5 DADE attB::PtatA (tatAG33C) This study 
SK6 DADE attB::PtatA (tatAS35C) This study 
SK7 DADE attB::PtatA (tatAF39C) This study 
SK8 DADE attB::PtatA (tatAK41C) This study 
SK9 DADE attB::PtatA (tatAD45C) This study 
SK10 DADE attB::PtatA (tatAE47C) This study 
SK11 DADE attB::PtatA (tatAT60C) This study 
SK12 DADE attB::PtatA (tatAT78C) This study 
SK13 DADE attB::PtatA (tatAV89C) This study 
 
Table 1. Strains used in this study 
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plasmid Description Reference 
pUNITATA Wild type tatA in pBluescript KS+ (30) 
pUNITATB Wild type tatB in pBluescript KS+ (22) 
pUNITATAX#C As pUNITATA, tatA harboring single cysteine codon 
substitution as indicated* 
This study 
and (30) 
pUNITATAins2C As pUNITATA, tatA harboring a cysteine codon insertion 
between codons 1 and 2.  
This study 
pUNITATAins21C As pUNITATA, tatA harboring a cysteine codon insertion 
between codons 21 and 22.  
This study 
pUNITATBX#C As pUNITATB, tatB harboring single cysteine codon 
substitution as indicated* 
This study 
and (22) 
pUNITATCC4 tatABC operon in pQE60, all 4 cysteine codons in tatC 
substituted for alanine codons 
(22) 
pUNITATCC4AX#C As pUNITATCC4 harboring single cysteine codon 
substitutions in tatA as indicated* 
This study 
and (30) 
pUNITATCC4Ains2C As pUNITATCC4 tatA harboring a cysteine codon insertion 
between codons 1 and 2 
This study 
pUNITATCC4Ains21C As pUNITATCC4 tatA harboring a cysteine codon insertion 
between codons 21 and 22 
This study 
pUNITATCC4BX#C As pUNITATCC4 harboring single cysteine codon 
substitutions in tatB as indicated* 
This study 
and (22) 
pKSuniA WT tatA under control of the tat promoter in pBluescript 
KS+ 
This study 
pKSuniAx#C As pKSuniA harboring single cysteine codon substitutions in 
tatA as indicated* 
This study 
pKSuniAins2C As KSuniA, tatA harboring a cysteine codon insertion 
between codons 1 and 2. 
This study 
pUNICC‒AX#C tatA promoter and tatABC operon in pQE60, no cysteine 
codons in tatC, single cysteine substitutions in tatA as 
indicated* 
This study 
pUNICCins2C tatA promoter and tatABC operon in pQE60, no cysteine 
codons in tatC, tatA harboring a cysteine codon insertion 
between codons 1 and 2. 
This study 
pRSUNICC‒AX#C tatA promoter and tatABC operon in pRS552, no cysteine 
codons in tatC, single cysteine substitutions in tatA as 
indicated* 
This study 
pRSUNICCins2C tatA promoter and tatABC operon in pRS552, no cysteine 
codons in tatC, tatA harboring a cysteine codon insertion 
between codons 1 and 2. 
This study 
pRSUNIAX#C tatA promoter and tatA (without tatBC) in pRS552, single 
cysteine substitutions in tatA as indicated* 
This study 
pRSUNICCins2C tatA promoter and tatA (without tatBC) in pRS552, tatA 
harboring a cysteine codon insertion between codons 1 and 
2. 
This study 
pVS005 P. panthotrophus soxYZ expression plasmid  (35) 
pHASoxYZ E. coli tatA promoter controlling expression of P. 
panthotrophus HA-soxY and soxZ in pSU20 
(38) 
pTH19SoxYZ E. coli tatA promoter controlling expression of P. 
panthotrophus HA-soxY and soxZ in pTH19cr 
This study 
pQE60-SufI Full length sufI gene cloned in vector pQE60  (55) 
*In constructs with single cysteine substitutions of tatA and tatB, X represents the single letter amino acid code and # represents the 
position of the substituted codon. 
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FIGURE S1. E. coli remains viable after EDTA treatment and sulfhydryl labelling. Strains MF1 
(WT) or MF2 (G2C) were grown in 50 ml LB medium harvested and resuspended in 1 ml buffer. 80 
µl aliquots of cell suspension were incubated with buffer alone, or with 5 mM EDTA in the presence 
or absence of 5 mM MAL-PEG for 1 hour at room temperature. After this time, 3 µl aliquots of each 
sample were inoculated, in triplicate, into 300 µl LB medium and cultured with aeration in a 96 well 
plate reader and the optical density at 600 nm was monitored for ten hours. Data points and error bars 
correspond to the mean ± SD (n=3). Samples are buffer alone (WT open diamond; G2C closed 
diamond), 5 mM EDTA treatment (WT open circle; G2C closed circle) or 5 mM EDTA PLUS 5 mM 
MAL-PEG treatment (WT open triangle; G2C closed triangle).  
 
FIGURE S2. Periplasmic TMAO reductase activities of E. coli strains producing plasmid-encoded 
TatA variants. Relative TMAO reductase activities were determined from the periplasmic fractions of 
strains DADE-P (ΔtatABCD, ΔtatE, pcnB1) harboring either pQE60, or pQE60 encoding TatB and 
cysteine-less TatC along with TatA variants containing a single cysteine substitution as indicated. The 
TMAO reductase activity of strain DADE-P transformed with pUNITATCC4, encoding wild type 
TatA (along with TatB and cysteine-less TatC), was defined as one hundred percent activity and 
corresponds to 9.5 µM benzyl viologen oxidised per minute and per mg of protein. The error bars 
represent standard error of the mean, n = 3. 
 
FIGURE S3. Levels of TatA variants produced from single copy tatA genes present at the 
chromosomal attB site. Crude membrane fractions were prepared from 50 ml cultures of E. coli 
strains expressing either A. the tatABC operon (strains MF1 - 13) or B. tatA only (strains SK1 - 13) 
from the chromosomal lambda phage attachment site. Crude membrane fractions (20 µg) were 
separated by SDS-PAGE (15% acrylamide), electroblotted, and immunoreactive bands of TatA were 
detected using anti-TatA antiserum. Expression levels of strains producing the indicated cys variant 
are compared to strains MC4100 (WT), DADE (Δ) and either MF1 (DADE attB::PtatA (tatABC); panel 
A) or SK1 (DADE attB::PtatA (tatA); panel B) 
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